<SEC-DOCUMENT>0001493152-23-044905.txt : 20240308
<SEC-HEADER>0001493152-23-044905.hdr.sgml : 20240308
<ACCEPTANCE-DATETIME>20231214170959
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001493152-23-044905
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20231214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telomir Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001971532
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				872606031
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		900 WEST PLATT STREET, SUITE 200
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606
		BUSINESS PHONE:		(813) 864-2562

	MAIL ADDRESS:	
		STREET 1:		900 WEST PLATT STREET, SUITE 200
		CITY:			TAMPA
		STATE:			FL
		ZIP:			33606
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="formcorresp_001.jpg" ALT="" STYLE="height: 66px; width: 150px"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTORNEYS
                                            AT LAW</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100
    North Tampa Street, Suite 2700 Tampa,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FL
    33602-5810 P.O. Box 3391</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampa,
    FL 33601-3391</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">813.229.2300
    TEL</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">813.221.4210
    FAX</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">www.foley.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WRITER&rsquo;S
    DIRECT LINE 813.225.4122</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ccreely@foley.com</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
14, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Via
EDGAR</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">United
States Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Life Sciences</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
DC 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Tara Harkins, Lynn Dicker, Jimmy McNamara, and Joshua Gorsky</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telomir
    Pharmaceuticals, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration
    Statement on Form S-1</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    November 14, 2023</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No. 333-275534</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Ms. Harkins, Ms. Dicker, Mr. McNamara, and Mr. Gorsky:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of Telomir Pharmaceuticals, Inc. (the &ldquo;Company&rdquo;), we are responding to the comments of the staff of the Division of
Corporation Finance of the United States Securities and Exchange Commission set forth in your letter to Dr. Christopher Chapman, the
Company&rsquo;s Chief Executive Officer, dated November 28, 2023, relating to the above-referenced filing. Your comments are reproduced
below in italicized bold text, followed by our responses on behalf of the Company. Please be advised that the Company is concurrently
filing via EDGAR an Amendment No. 1 to the Registration Statement on Form S-1 (the &ldquo;Registration Statement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Registration
Statement on Form S-1</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Prospectus
Summary</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Pre-Clinical
Studies, page 4</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>1.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your response to comment 11, including your revised disclosure that all preclinical studies described in this section were conducted
    &ldquo;with&rdquo; the assistance of &ldquo;any&rdquo; third parties. Please clarify here, and in the Business section, whether all
    the referenced studies were conducted with or without third party assistance.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has revised its disclosure in the Registration Statement to state that it received assistance from
third parties. Specifically, on page 4 of the Registration Statement, the Company states that &ldquo;[a]ll pre-clinical studies described
in this prospectus were conducted with the assistance of third parties.&rdquo; Further, the Company revised its disclosure relating to
each study performed and described in the Business section to state which third party provided assistance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">AUSTIN</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">Boston</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">CHICAGO</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">dallas</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DENVER</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">DETROIT</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">houston</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">JACKSONVILLE
    </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">LOS
    ANGELES</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MADISON</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MEXICO
                                            CITY</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MIAMI</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">MILWAUKEE
    </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">NEW
    YORK</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">ORLANDO
    </FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SACRAMENTO</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">salt
    lake city</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SAN
    DIEGO</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SAN
    FRANCISCO</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">SILICON
    VALLEY</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TALLAHASSEE</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TAMPA
    </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">WASHINGTON,
    D.C.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">BRUSSELS</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">TOKYO</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
14, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
2 of 3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Intellectual
Property, page 5</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
note your disclosure regarding Mr. Williams&rsquo; background as it relates to his &ldquo;design of novel small molecule therapeutics&rdquo;
as well as his work &ldquo;collaborat[ing] closely with a leading expert in tobacco chemistry at the University of Kentucky[.]&rdquo;
Please balance your disclosure to clarify, if true, that Mr. Williams does not hold any formal degrees in chemistry or certifications
related to the development of pharmaceuticals.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has revised its disclosure on pages 5 and 60 of the Registration Statement to state that Mr. Williams
does not hold any formal degrees in chemistry or certifications related to the development of pharmaceuticals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>3.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your disclosure that Mr. Williams is the &ldquo;sole inventor of TELOMIR-1&rdquo; and that his work on TELOMIR-1 &ldquo;began
    in late 2020.&rdquo; We also note your citation to a study conducted by Donald R. Burgess in 2004, which appears to compare the structure
    of TELOMIR-1 with iron. Please reconcile this disclosure, or otherwise advise.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has removed the citation and reference to the study conducted by Donald R. Burgess in 2004. Mr. Burgess
did not compare the structure of TELOMIR-1 with iron, and Mr. Williams is the &ldquo;sole inventor of TELOMIR-1&rdquo; and his work did
begin in late 2020. Please also be advised that the Company has replaced the citation to Mr. Burgess with the following: &ldquo;InSilicoTrials;
Insilico Affinity Computations Between TELOMIR-1 and DIEN to FE<SUP>+2</SUP> ions in Water Solution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Capitalization,
page 41 </U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>4.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your capitalization table includes &ldquo;other liabilities,&rdquo; which consists of &ldquo;trade accounts payable and accrued
    liabilities&rdquo; and &ldquo;accrued interest.&rdquo; Since &ldquo;trade accounts payable and accrued liabilities&rdquo; are current
    liabilities and are not part of your capital structure, please remove these line items from your table.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has removed the line item &ldquo;other liabilities&rdquo; in the capitalization table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Business</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Post-Chemotherapy
Recovery, page 49</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>5.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your reference to the British Journal of Clinical Pharmacology has a footnote, but no corresponding information. Please delete
    or otherwise advise.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has removed the footnote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>In
silico Affinity Studies, page 54</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>6.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your response to prior comment 10. We reissue our comment in full. We continue to note your disclosure that &ldquo;[y]our pre-clinical
    studies demonstrate that TELOMIR-1 may uniquely and selectively bind critical metals to interrupt enzyme function . . . and turn
    off the underlying cause of cancer development and growth.&rdquo; Please revise your disclosure here, and elsewhere as appropriate,
    to remove the implication that your product is safe or effective as such conclusions are within the sole authority of the FDA and
    comparable foreign regulators.</I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has revised its disclosure to remove the following language: &ldquo;and turn off the underlying
cause of cancer development and growth.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>General</U></I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: .25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>7.</I></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
    note your response to comment 12 and reissue. Please ensure the writing is legible in the visual depictions throughout your draft
    registration statement. For example only, certain text on pages 50-52 is not legible. </I></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
Please be advised that the Company has revised its disclosure here and throughout the Registration Statement to replace the illegible
visual depictions with high-resolution images and text.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
14, 2023</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
3 of 3</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Should
you have any additional questions, please do not hesitate to contact the undersigned at 813.225.4122.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Best
    regards, </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Curt P. Creely</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt
    P. Creely</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>formcorresp_001.jpg
<TEXT>
begin 644 formcorresp_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !" )8# 2(  A$! Q$!_\0
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M%^CVTES KW=EX4\5?#OP1I.NM;6C7$QM9/%FA&YFBBA2X@65I(OPT_X-PO\
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MJZ7;YU3Q+KLUM#;6USXC\5ZU-J/B;Q)>06UM#>:[JVH745O!'*L*% 'X4_\
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MM)4 ?Z"'_!)W_E%E_P $T_\ LP#]C?\ ]9U^'-??]? '_!)W_E%E_P $T_\
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MID!\,_$SPS_8VLP2Z1JVN^%6\*?$;P1J,&I7-YX)\51V#3*-:T*YMHOZL?\
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MN+'4+"YN+2[@EMYI(VW<8_(#J3TSCK]>O4]Z6@#_ "T?^"E__!N;_P %#_\
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M (4D;;_A5_C;^Q!X^_X601X$_LX^(O[)^P?\)/\ \2\ZW_9@C!OC9U_I/T4
M?Y1/_!?3_@G=_P % _C/_P %=OVTOB7\'_V%/VROBI\.?$_COPK<>&?'_P .
MOV7OCAXT\%>)+:S^&/@?3KJZ\/\ BGPYX%U'0]:M(+^TN[*2ZTR^NK875M<0
M>;YD,BK\\1Q_\'2T,<<44?\ P7[BBB18XHHU_P""B21QQHH5(XT4!41% 554
M!54    "O]?VB@#_ ##_ /@D]_Q$0_\ #R+]C/\ X:@_X?4_\,_?\+T\(_\
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M'^@_LT?%>_\ &7B7X7VGAC4/'7A#Q7\+_B_\&O&FA:1XTM[RZ\*:^?!GQN\
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M_"?5=,A\+:=XFTO5[/Q[XETKQ_HVD>'?"G@:WU&XE$EG=LP!^MGQQ_X+*?\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
